These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Effervescent and standard formulations of ranitidine--a comparison of their pharmacokinetics and pharmacology. Watson RG, Johnston BT, Tham TC, Kersey K. Aliment Pharmacol Ther; 1996 Dec; 10(6):913-8. PubMed ID: 8971288 [Abstract] [Full Text] [Related]
25. Comparison of 200 mg cimetidine with multiple doses of antacid on extent and duration of rise in gastric pH in volunteers. Thomson AB, Kirdeikis P, Zuk L. Dig Dis Sci; 1999 Oct; 44(10):2051-5. PubMed ID: 10548357 [Abstract] [Full Text] [Related]
26. The effect of antacid and ranitidine on droxicam pharmacokinetics. Bartlett A, Costa A, Martínez L, Roser R, Sagarra R, Sánchez J. J Clin Pharmacol; 1992 Dec; 32(12):1115-9. PubMed ID: 1487550 [Abstract] [Full Text] [Related]
27. Comparison of the antacid properties of almagate and aluminium hydroxide against pentagastrin-induced gastric secretion in healthy volunteers. Balanzó J, Guarner C, Vilardell F. Arzneimittelforschung; 1984 Dec; 34(10A):1375-7. PubMed ID: 6439225 [Abstract] [Full Text] [Related]
31. Radiotelemetric comparison of two antacids using the Heidelberg capsule. Gómez Puch LM, Ríos Solans G, Muñoz y Fernandez JR. Arzneimittelforschung; 1984 Dec; 34(10A):1378-80. PubMed ID: 6548925 [Abstract] [Full Text] [Related]
32. [Bioequivalence and bioavailability after single administration of effervescent ranitidine tablets]. Hartmann B, Schmieder G, Tetzloff W, Töberich H. Arzneimittelforschung; 1992 Aug; 42(8):1020-2. PubMed ID: 1418073 [Abstract] [Full Text] [Related]
33. Effect of an aluminum- and magnesium-containing antacid on the bioavailability of garenoxacin in healthy volunteers. Krishna G, Kisicki JC, Olsen S, Grasela DM, Wang Z. Pharmacotherapy; 2007 Jul; 27(7):963-9. PubMed ID: 17594201 [Abstract] [Full Text] [Related]
35. Effects of tablet and effervescent formulations of ranitidine 75 mg and cimetidine 200 mg on gastric acidity and oesophageal acid exposure in healthy humans. Bruley des Varannes S, Duquesnoy C, Mamet JP, Slama A, Galmiche JP, Scarpignato C. Aliment Pharmacol Ther; 1998 Nov; 12(11):1155-61. PubMed ID: 9845405 [Abstract] [Full Text] [Related]
36. Twenty-four-hour intragastric pH: tolerance within 5 days of continuous ranitidine administration. Lachman L, Howden CW. Am J Gastroenterol; 2000 Jan; 95(1):57-61. PubMed ID: 10638559 [Abstract] [Full Text] [Related]
37. Oral bioavailability of nizatidine and ranitidine concurrently administered with antacid. Desager JP, Harvengt C. J Int Med Res; 1989 Jan; 17(1):62-7. PubMed ID: 2565267 [Abstract] [Full Text] [Related]
38. Investigation of the possible influence of the absorption of vinpocetine with concomitant application of magnesium-aluminium-hydroxide gel. Lohmann A, Grobara P, Dingler E. Arzneimittelforschung; 1991 Nov; 41(11):1164-7. PubMed ID: 1810262 [Abstract] [Full Text] [Related]
39. Intragastric pH after oral administration of single doses of ranitidine effervescent tablets, omeprazole capsules and famotidine fast-dissolving tablets to fasting healthy volunteers. Hedenström H, Alm C, Kraft M, Grahnén A. Aliment Pharmacol Ther; 1997 Dec; 11(6):1137-41. PubMed ID: 9663842 [Abstract] [Full Text] [Related]
40. Efficacy in vivo of almagate in neutralising histamine-induced acid secretion in a rat re-perfused stomach preparation. Llupiá J, Beckett PR, Lumachi B, Roberts DJ. Arzneimittelforschung; 1984 Dec; 34(10A):1370-2. PubMed ID: 6548923 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]